Nuheara IQBuds Max vs Otofonix Encore

The Nuheara IQBuds Max is a budget-priced OTC hearing aid that earns a B grade with a SoundScore of 3.4/5 in our lab testing. At $499, it sits in the affordable tier of the OTC category, ranking #46 of 65 devices tested. The standout performance area for the IQBuds Max is music streaming, which scores a strong 4.3/5—significantly above the category average by 2.38 points. This makes it one of the better choices in the OTC space for users who prioritize audio entertainment alongside hearing assistance. However, speech performance presents a mixed picture: speech in quiet scores 2.0/5, falling 0.78 points below the category average, while speech in noise scores a low 1.5/5, though this is essentially at the category average. Own-voice comfort is mixed at 2.2/5, sitting slightly below the category average. Feedback handling scores a solid 3.4/5 in absolute terms, though this is 1.14 points below the category average of 4.54/5. The device features rechargeable batteries and supports both iPhone and Android streaming with hands-free capability. The IQBuds Max is best suited for users who want an affordable entry into amplification with strong music streaming performance, but who have modest expectations for speech clarity improvement. Those prioritizing speech understanding may want to consider higher-ranked alternatives in the same price range, such as the Elehear Beyond or Apple AirPods Pro 2.

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.